Could a cancer drug help kids with rare pitt hopkins syndrome?
NCT ID NCT07150026
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 31 times
Summary
This early study tests the safety and effects of vorinostat, a drug currently used for cancer, in 5 people with Pitt Hopkins syndrome (ages 3-21). Each person will try a placebo and two different doses of the drug to see if it helps with symptoms and is safe. The goal is to gather information for larger future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PITT HOPKINS SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Grupo de Investigación Clínica PECET (GIC-PECET)
RECRUITINGMedellín, Colombia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.